← Back

Wire · operational-macro

Virtuoso Robotic System Earns FDA De Novo Nod for En Bloc Bladder Resection

Published

11 November 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at cancernetwork.com →

◆ Verified

Fusion42 · 11 November 2026 · Fusion42 review

FDA granted De Novo authorization to the Virtuoso robotic endoscopy system for en bloc bladder lesion resection to obtain tissue samples including detrusor muscle, based on safety and efficacy data from the VIABLE trial. The system uses robotic arms controlled via a console to improve precision and is planned for US launch in 2027.

This Wire brief sits within Fusion42's coverage of Medtech, and 5 sources have reported it between 10 Nov 2026 and 16 Nov 2026.

◆ ◆ The Wire takeaway

You face a new FDA-approved tool that lets surgeons remove bladder lesions with better tissue quality and fewer complications. If your medtech product competes in urology, now is the time to highlight robotic precision benefits or prepare for increased competition.

◆ Coverage

5 sources · first reported 10 Nov 2026 · latest 16 Nov 2026

◆ Related on Wire

◆ Topics

MedtechFDA-approvalrobotic-surgerybladder-cancermedtech-innovationclinical-trial